Novo CEO pressed by Senate to chop rates of obesity, diabetic issues medications CEO Lars Fruergaard Jørgensen informed lawmakers the organization would contemplate new talks with insurers regarding the listing rates of Wegovy and copyright whenever they pledge to help keep the medicines on their own formularies. Insurers will continue https://kethek.com/